Skip to content

Application of humidified high-flow nasal cannula in fiberoptic bronchoscopy sedation

Application of humidified high-flow nasal cannula in fiberoptic bronchoscopy sedation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072095
Enrollment
Unknown
Registered
2023-06-02
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fiberoptic bronchoscopy,Hypoxemia,Sedation anesthesia

Interventions

Control group(routine oxygen therapy via nasal cannula):routine oxygen therapy via nasal cannula (5L/min)
HFNC25L/min(25L/min humidified high-flow oxygen therapy):humidified high-flow oxygen therapy administered with a flow rate of 25L/min
HFNC45L/min(45L/min humidified high-flow oxygen therapy):humidified high-flow oxygen therapy administered with a flow rate of 45L/min
HFNC65L/min(65L/min humidified high-flow oxygen therapy):humidified high-flow oxygen therapy administered with a flow rate of 65L/min

Sponsors

Beilun People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1: The age range is 18-60 years 2: ASA grade I or II 3: No other severe systemic complications 4: Clear consciousness, can cooperate with the examination and treatment 5: The patient gave informed consent and signed the written informed consent

Exclusion criteria

Exclusion criteria: 1: Those who do not meet the inclusion criteria 2: Patients with cardiovascular, hepatic, renal, hematopoietic, neurological, or systemic disease 3: Patients with a history of alcohol abuse or long-term use of opioids or sedatives 4: Patients with severe cognitive impairment 5: Patients with a history of COPD or asthma 6: Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Oxygenation;VAS Score of Cough response;adverse reaction;Comfort level of oxygen intake;Satisfaction to sedation by bronchoscopist;

Secondary

MeasureTime frame
postoperative recall;Heart rate;Blood pressure;the willingness to return for a second FB examination;

Countries

China

Contacts

Public ContactXu Rong

Beilun People's Hospital, Ningbo, Zhejiang

516069717@qq.com+86 134 5612 8640

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026